Mazdak M. Bradberry - The Consciousness Library

Papers

Informed Consent in Psychedelic-Assisted Therapy.

Current Topics in Behavioral Neurosciences December 31, 2024 Mazdak M. Bradberry, Paul S. Appelbaum, Natalie Gukasyan 7 citations

Informed consent in psychedelic therapy requires clear communication of risks and potential benefits, as classical serotonergic psychedelics like psilocybin and entactogens like MDMA are increasingly used in Western clinical settings. Rigorous informed consent standards are essential for quality care and risk mitigation, especially in research and for vulnerable individuals. This chapter outlines practical elements of informed consent for these treatments based on current understanding.

DOI: 10.1007/7854_2024_559 Full text MDMA Psilocybin Psychedelic-assisted therapy Medical consent +5

Papers

Toward Risk-Benefit Assessments in Psychedelic- and MDMA-Assisted Therapies

Informed Consent in Psychedelic-Assisted Therapy.